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Abstract
Dorsal root ganglion (DRG) neurons provide connectivity between peripheral tissues and the spinal cord. Transcriptional plasticity
within DRG sensory neurons after peripheral nerve injury contributes to nerve repair but also leads tomaladaptive plasticity, including
the development of neuropathic pain. This study presents tissue and neuron-specific expression profiling of both known and novel
long noncoding RNAs (LncRNAs) in the rodent DRG after nerve injury. We have identified a large number of novel LncRNAs
expressed within the rodent DRG, a minority of which were syntenically conserved between the mouse, rat, and human, and
including, both intergenic and antisense LncRNAs. We have also identified neuron type–specific LncRNAs in the mouse DRG and
LncRNAs that are expressed in human IPS cell–derived sensory neurons. We show significant plasticity in LncRNA expression after
nerve injury, which in mice is strain and gender dependent. This resource is publicly available and will aid future studies of DRG
neuron identity and the transcriptional landscape in both the naive and injured DRG.We present our work regarding novel antisense
and intergenic LncRNAs as an online searchable database, accessible from PainNetworks (http://www.painnetworks.org/). We
have also integrated all annotated gene expression data in PainNetworks, so they can be examined in the context of their protein
interactions.
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1. Introduction
Dorsal root ganglion (DRG) neurons provide connectivity between
peripheral targets and the spinal cord. These neurons show
significant heterogeneity in relation to their morphology, func-
tional properties, growth factor dependence, and transcriptional
profile.1,4,63 This reflects the highly specialised nature of these
neurons subserving distinct sensory modalities, including tem-
perature, pain, itch, touch, and proprioception. Recent single-cell
RNA-seq studies have provided a means to classify these
neurons and have identified multiple DRG neuron sub-
groups.38,67 Pathologies of DRG neurons—for instance, in the
form of acquired or inherited peripheral neuropathies—have
a significant impact on human health as a consequence of
sensory loss and neuropathic pain12 and are destined to become
more common with an ageing population and increased
prevalence of type II diabetes.
A wide variety of injuries applied to sensory neurons, whether
traumatic or metabolic, result in marked alterations in transcrip-
tion of protein-coding genes.13,34,53 Such changes can have
either beneficial or maladaptive outcomes, including increased
expression of regeneration-associated genes9,51 and altered
expression of ion channels resulting in enhanced DRG neuronal
excitability and neuropathic pain. The DRG has therefore become
a model system to study the transcriptional changes after injury.
This focus on RNAs’ encoding proteins is understandable, given
their obvious link with function. However, there are other types of
RNA and one of these, long noncoding RNA (LncRNA) has been
relatively neglected and little studied in the context of sensory
neurones.
LncRNAs are usually multiexonic transcripts of more than 200
base pairs that can modulate gene expression through cis and
trans signalling, and have important functional effects.6,31,58,69,76
The mechanisms by which LncRNAs may alter gene expression
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are very diverse, including: complementary binding of antisense
LncRNAs, transcriptional interference at promoter sites, altered
chromatin structure, competing for miRNA binding, and binding
to transcription factors.26,44,81
Ion channels are key determinants of the excitability and hence
the functional properties of sensory neurons. Antisense LncRNAs
have previously been identified to the voltage-gated potassium
channel, KCNA2,86 and the voltage-gated sodium channel,
SCN9A.32 In the former case, induction of the antisense LncRNA
after nerve injury was shown to result in reduced expression of
KCNA2 (which acts as an excitability break), leading to sensory
neuronal hyperexcitability and the development of neuropathic
pain. These are selected examples of functionally relevant
LncRNAs that illustrate the important role they can play. However,
there has, to date, been no comprehensive analysis of LncRNA
expression within the DRG partly because LncRNAs are typically
expressed at low levels and are known to vary by species, tissue,
and developmental stage.31,68 Our aimwas to use high-coverage
RNA-seq combined with a dedicated bioinformatics platform to
identify as comprehensively as possible LncRNAs expressed in
the DRG.We compared rats and 2 different mouse strains (which
show differing degrees of mechanical hypersensitivity after nerve
injury67). We wished to determine whether LncRNAs were
expressed in a cell-type–specific manner and also to assess the
effect of nerve injury on LncRNA expression. In addition, we also
assessed LncRNA expression in human Induced Pluripotent
Stem Cell –derived sensory neurons.
2. Material and methods
Seventeen supplementary spreadsheets are available at http://
doi.org/10.6084/m9.figshare.6508205, and 18 tables, 10 fig-
ures, and supplementary methods are in supplementary digital
content (available at http://links.lww.com/PAIN/A676).
2.1. Data availability
Data are in GSE107182 super series that consists of GSE107180
(rodents’ DRG) and GSE107181 (human IPSC). Splicing junc-
tions (SJ), differentially expressed (DE) data analysis results, and
GTF files with annotations used are included as downloadable
supplementary files of the GEO series GSE107180 and
GSE107181. Supplemental data spreadsheets are available at
http://doi.org/10.6084/m9.figshare.6508205.
IGV genome browser tracks for novel LncRNAs are publicly
available.
Mouse: https://storage.googleapis.com/lncrnatracks/Mouse_
DRG_LncRNAs/Novel_lncRNAs_mouse_DRG.gtf (from IGV ver-
sion 2.4x); gs://lncrnatracks/Mouse_DRG_LncRNAs/Novel_lnc
RNAs_mouse_DRG.gtf (until IGV version 2.3x).
Rat: https://storage.googleapis.com/lncrnatracks/Rat_DRG_
LncRNAs/Novel_lncRNAs_rat_DRG.gtf (from IGV version 2.4x);
gs://lncrnatracks/Rat_DRG_LncRNAs/Novel_lncRNAs_rat_
DRG.gtf (until IGV version 2.3x).
Human IPSC: https://storage.googleapis.com/lncrnatracks/
Human_IPS_LncRNAs/Novel_lncRNAs_IPS.gtf (from IGV version
2.4x); gs://lncrnatracks/Human_IPS_LncRNAs/Novel_lncRNAs_I
PS.gtf (until IGV version 2.3x).
Processed RNA-seq mouse DRG samples for IGV genome















All data have been integrated to PainNetworks. In http://
www.painnetworks.org, the user can examine a gene (or set of
genes) of interest alongside known interaction partners on the
protein level. This information is displayed by the resource in the
form of a network. Moreover, the user can access all expression
data (log2 fold change and false discovery rate–adjusted P
values) and download these in the formof spreadsheets. A tutorial
on how to use PainNetworks can be accessed following this link
http://www.painnetworks.org/tutorials/RefMan.pdf.
All intergenic and antisense LncRNAs’ profiling data are
accessible in PainNetworks (http://www.painnetworks.org) →
ExpressionData → Mouse centric/Rat centric/Human centric.
Experiment names are GB-BALBC-LNCRNAS for the BALB/c
mouse, GB-SNI-B10D2-LNCRNAS for the B10.D2 mouse, GB-
RAT-LNCRNAS for the rat, and IPSC_HS_AD2-LNCRNAS for
IPSC-derived neurons. Naming is as follows: Closest {gene or
sense gene}_LNCRNA_{IG or nothing}_chr:start-end(strand).
Examples:
ENSMUSG00000000093_LNCRNA_IG:11:85830666-85831495
(1) is the intergenic LncRNA with coordinates 11:85830666-
85831495(1) close to the ENSMUSG00000000093 gene.
ENSMUSG00000000094_LNCRNA:11:85897018-85900613(2)
is the antisense LncRNA with coordinates 11:85897018-85900613
(2) on the opposite strand of ENSMUSG00000000094 gene.
2.2. Animals: welfare, tissue, and sample collection
2.2.1. Rat
All procedures on rats were performed in accordancewith UK home
office regulations and in line with the Animals Scientific Procedures
Act 1986 at a licensed facility at King’s College London. Animals
were group housed in temperature- and humidity-controlled rooms
where food and water was available ad libitum, with a 12-hour
light–dark cycle. The welfare of all animals was continually assessed
throughout all procedures. In total, 24 rats were used.
Rats were humanely culled. L5 DRG tissue from male Wistar
rats was collected 21 days after the spinal nerve transection (SNT)
surgery, placed into sterile tubes, frozen on dry ice, and stored at
280˚C. Each sample comprises 3 pooled animals, and we had 4
samples of each condition (SNT vs sham).
2.2.2. Mouse
All procedures in mice were performed in McGill University,
Montreal, Canada, were approved by the McGill University Animal
Care Committee and are fully consistent with Canadian Council on
Animal Care guidelines. All mice strains were procured from
Jackson Laboratories (Bar Harbor, ME) at 4 to 8 weeks of age. All
animals of the same sex were group housed in a vivarium at21˚C
in standard shoebox cages, 2 to 4 per cage, with access to food
(Harlan Teklad 8604; Envigo, Huntington, United Kingdom) and tap
water ad libitum. Average weights were 20.2 (SD5 2.89) for BALB/
cmice and 21.4 (SD5 3.48) for B10.D2mice (N5 12 per strain; for
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each strain, 6 spared nerve injury [SNI]–6 Shamstratified for sex). All
operations were performed on adult mice. Brain and DRG tissue
has also been dissected from 3 wild-type mice (C57/bl6) and was
used to determine relative expression of mRNA using quantitative
real-time polymerase chain reaction (qPCR) (see below). In total, 27
mice were used.
The tip of the iliac bone, “the first articular process more than
1 mm rostral to the iliac crest,”61 was used as the landmark for
identifying the L5 DRG in all samples. L3 and L4 DRG were
dissected from all mice 28 days after peripheral nerve injury. Each
sample represents 1 animal and consists of both L3 and L4 DRG.
Twelve BALB/c mice and 12 B10.D2 mice stratified for condition
and sex were used. All dissections were performed on dry ice, and
RNase Decontamination Solution was used to prevent RNA
degradation. Tissue was placed into sterile Eppendorf tubes and
initially stored on dry ice. For long-term storage, samples were
stored in a 280˚C freezer.
2.2.3. IPS-derived human neurons
Human fibroblast–derived IPSC was generated as described
previously.11 Neural differentiation was performed using8 the
protocol with modifications.
2.3. Animal models of pain
2.3.1. Mouse spared nerve injury
The surgical procedure for SNI followed a published protocol
developed for rats15 and adapted for mice.64 Under general
anaesthesia (isoflurane and oxygen), the common peroneal and
the sural branch of the sciatic nerve were cut and the tibial branch
spared. For sham surgery, the same surgical and anaesthetiza-
tion procedures were followed, but the nerve branches were
simply exposed and not damaged. We assessed mechanical
hypersensitivity after SNI surgery on the ipsilateral mouse paw.
2.3.2. Rat spinal nerve transection
The left L5 spinal nerve was ligated and transected, and the L4
and L6 branches were left intact. In sham animals, the spinal
nerve was exposed but not ligated.
2.3.3. Behavioural tests
The behavioural test was conducted in a specially allocated room
in the animal facility unit at McGill University, performed at
a consistent time of the day and by the same experimenter. Mice
habituated to the vivarium for at least 1 week before testing.
Mechanical pain–related hypersensitivity in mice was assessed
using von Frey filaments and the up-down method of Dixon10 to
determine the 50% withdrawal threshold. Mice were first
acclimatised to behaviour equipment and baseline behaviour
performed 3 times and an averagewas calculated before surgery.
Baseline paw withdrawal threshold was 1.27 g (SD 5 0.22) for
BALB/c strain and 1.36 g (SD5 0.23) for B10.D2 strain (N5 12).
Mice were assigned to the sham or SNI group randomly and
postinjurymechanical sensitivity tested at day 1, 7, 14, 21, and 28
(N5 12 per strain stratified for sex and condition, 6 SNI–6 Sham
mice per strain). Assuming an effect of 30% and an SD 5 20%,
we need an N 5 6 to achieve power 5 80 at an a 5 0.05 two-
sided 1-way analysis of variance (ANOVA). Mice from both strains
and surgery groups were tested on the same day. The
experimenter was not informed about the condition (injury vs
sham) of animals but could not be blinded because of the coat
colour of the different strains.
2.4. RNA isolation and library preparation
RNA was extracted using a hybrid method of phenol extraction
(TriPure; Roche, Welwyn Garden City, United Kingdom) and
combined with column purification (High Pure RNA tissue Kit;
Roche).14 Dorsal root ganglion samples were first homogenised
in TriPure using a handheld homogeniser (Cole-Palmer, Saint
Neots, United Kingdom). For IPS cells, TriPure was added directly
to thewell after removal ofmedia. The concentration of RNA in the
samples was measured using a nanodrop. Total RNA was
provided to the sequencing centre, and the ribodepleted fraction
was selected for further sequencing. In rats, this was the
polyadenylated fraction. It was then converted to cDNA using
the strand-specific deoxy-UTP strand-marking protocol.
2.5. Sequencing and mapping
All samples were sequenced at the Oxford Genomics Centre.
Sequencingwas performed using the Illumina HiSeq4000 paired-
end protocol with 100 bp reads for the mouse DRG, 75 bp for
human IPSC/neurons, and Illumina HiSeq2000–100 bp reads for
the rat DRG.
The DRG from 24 mice (12 per strain stratified for sex and
condition) was sent for sequencing. During library preparation, 2
samples (sample 72 BALB/c SNI Male and sample 68 B10.D2
SNI Female) were accidentally mixed together and destroyed.
From the 22 samples sent for sequencing, 2 were excluded
(sample 59 B10.D2 SHAM Male and sample 66 BALB/c SNI
Female) because of having more ambiguously mapped reads,
lower percentage of mapped reads, and higher Cook’s distance
than all the other samples.
Mapping to the genome was done using STAR aligner.18
Reads were mapped on the mm10 mouse genome, rn6 rat
genome, and Hg38 human genome, all downloaded from
ENSEMBL. Conditions and strains were multiplexed in lanes
and library batches. Lanes were merged as BAM files after
mapping.39
2.6. Differentially expressed and counting features
Differentially expressed analysis was performed using DESeq242
default settings. Significant cutoff in all cases was false discovery
rate–adjusted P value ,0.05. Counting of features was done
using HTSeq3 and the intersection and not empty strategy to
resolve ambiguously counted reads.
All visualisations used regularised log2-transformed counts.42
Principal component analysis was always performed on regularized
log-transformed counts using the top 10,000 genes in mice and
humans, and 5000 genes in rats ranked by their SD. Hierarchical
clustering was done on regularised log2 counts of the whole gene
set, using Euclidean distances and complete linkage.
Gene Ontology (GO) enrichment for DE genes was carried in R
using top GO and GSEA.2,49 Enrichment of neuron subtype–
specific genes was calculated with the Fisher exact test, and
enrichment of Biological Process (BP) in network modules was
calculated using hypergeometric distribution.
2.7. Identification of novel LncRNAs
We used a customised reference–based transcript assembly
pipeline that requires a reference genome and gene set
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annotations. Workflow similar7,22,29 with modifications to pro-
duce annotations at the gene level. Doing this, we get a non-
redundant annotation of unique genes of LncRNAs suitable for
count-based DE analysis.3,42 The concept of islands of expres-
sion (I.o.E) is described in Ref. 22. Coverage cutoff has been set
as in Ref. 7.
Only properly paired and uniquely mapped reads were
selected. We selected SJs covered with .2 reads and with
lengths .20 and ,100,000. We discarded all reads over-
lapping annotated gene models. We then used the remaining
subset of RNA-seq reads to identify I.o.E outside known gene
models using a coverage window approach. Gene models
were extended by 1000 bp in each direction to ensure that
elongated untranslated regions (UTRs) or not yet annotated
exons would not be considered putative novel genes. We
selected continuous regions above the coverage threshold of
more than a read-mate length to ensure that overlapping read
mates would not artificially increase coverage. For I.o.E length
$100 and depth .2, I.o.E were identified using the function
“BAM_to_IOE.” Islands of expression were collapsed and
clustered as co-overlapping features connected by SJs. A
connectivity matrix was created holding all interconnecting
I.o.E. In each cluster, consensus introns were calculated by the
relative frequency of each discrete segment of a set of SJs. We
then subtracted the genomic intervals of these consensus
introns from the genomic intervals of the grouped (I.o.E) to
reconstruct full-length putative LncRNAs. For novel I.o.E with
no overlapping SJs, we first selected only the intersect of the
respective genomic regions across all samples. Then, mono-
exonic putative LncRNAs were kept for further analysis only if
the length-normalised coverage had Pr (.jZj), 0.1. Coverage
across I.o.E was fed into a smoothed z-score signal processing
algorithm. Z-score thresholding was used to identify introns
not identified by the aligner and sudden coverage drops
indicating end of transcription activity.5 Rolling coverage was
calculated over a smoothing window of 31 bp, and the
minimum coverage drop threshold was set to 5 and the
minimum intron length to 20 bp. We only kept novel intronic
genes if they were supported by evidence of novel splicing
junction and did not contain retained introns.
We included putative LncRNAs in this novel annotation only if
they were present in all replicates of a biological condition or
strain. Annotations were exported in the Gene Transfer Format
(GTF). Subsequently, we filtered out transcripts with length
,200 bp, and we used CPAT72 to assess coding potential.
An average expression cutoff threshold similar to Ref. 56 of
.0.5 fpkm for at least one condition was applied to novel
LncRNAs performed for downstream analysis. The pipeline
was scripted in R59 using bioconductor21 packages and
custom scripts. All iterative processes were executed in parallel
to optimise run times using parallel and BiocParallel.48,50,56
More details in supplementary methods are (available at http://
links.lww.com/PAIN/A676). All scripts of the workflow are
available in github: http://github.com/gbaskozos/
Scripts_LncRNAs.
2.7.1. Transcription start sites mapping to mm10
Transcription start sites (TSS) data were downloaded from
FANTOM 5 database.20,40 We downloaded TSS data that have
been classified as “True TSS” by the “TSS classifier.” The UCSC
Lift Over tool46 has been used to translate genomic coordinates
from themm9 genome to the mm10. Fifty-one percent of the true
TSS were unambiguously mapped to mm10.
2.8. Tissue specificity















2.9. Gene coexpression network
WGCNA23 was used to create a weighted gene coexpression
network. Analysis was performed only in mice, as it requires an
n .15. Weighted bicorrelation was used as a robust correlation
metric. An unsignednetworkwasconstructedusingonly genes that
had .10 counts in 25% of samples. Then, the top 25% of genes
ranked according to their median absolute deviations were used for
the analysis. Scale-free topologywas achievedwith a soft threshold
5 5. Modules detected with hierarchical clustering and dynamic
tree cut, minimummodule size5 30, cut height5 0.995, and deep
split 5 2. Merged threshold was 0.2. Module eigengenes were
calculated as the first principal component of eachmodule. Module
membership of LncRNAswas calculated as theabsolute (unsigned)
bicorrelation with the module eigengenes. The hypergeometric
distribution and the Fisher exact test were used to identify the top
GO-enriched (P value , 0.05) terms for each module.
2.10. Primer design
Primers for the detection of LncRNA and reference gene
expression were designed using Primer-BLAST (https://
www.ncbi.nlm.nih.gov/tools/primer-blast/). Primers were
designed not to overlap any other annotated gene. Thus, primers
designed for antisense LncRNAs were not able to detect regions
complementary to sense gene exons. Primer efficiency and
specificity were validated before experimental use.
2.11. Reverse transcription polymerase chain reaction
For qPCR analysis, RNA samples were converted into cDNA using
Evoscript Universal cDNA Master kit (Roche) and by following the
manufacturer’s instructions. This kit uses random primers. For
LncRNA2754, the primers designed also detected a putative UTR,
and therefore, a strand-specific real-time reaction was used.
Strand-specific RT primers (see table 18, available at http://
links.lww.com/PAIN/A676) were used for LncRNA2754 and for
HPRT1 (final concentration 0.5 mM), and 200 ng of RNA was used
for each reaction. Strand-specific reverse translation into cDNA
synthesis was performed using Transcriptor reverse transcriptase
(Roche) and dNTPs (Promega, Southampton, United Kingdom).
2.12. Quantitative real-time polymerase chain reaction
For qPCR analysis, cDNA (5 ng) and primer pairs (1 mM, see table
18, available at http://links.lww.com/PAIN/A676) were mixed with
LightCycler 480 SYBR Green Master (Roche) in a 1:1 ratio and
added to white 384-well plates (Roche). Plates were run on a 45-
cycle protocol using the LC 480 II system (Roche). Gene
expression for each mouse target primer was normalized against
the reference gene HPRT1, and the relative expression (delta CT)
was calculated. For human IPS cells, transcript expression was
normalised against the average CT of GAPDH and HPRT1. For
each target, transcript expression is shown relative to a control
group (eg, Sham). Significancewas calculated usingANOVAwith a
design of; sex1 condition for eachmouse strain and; condition
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for human IPSC averaging over all cell lines. N 5 10 per strain (6
Sham–4 SNI for BALB/c, 5 Sham–5 SNI for B10.D2; for strand-
specific qPCR, B10.D2 strain N 58, 5 Sham–3 SNI). Quantitative
real-time polymerase chain reaction was also used to assess
relativemRNAexpression in brain vsDRG,N5 3. Significancewas
calculated using 1-way ANOVA.
2.13. In situ hybridisation
In situ hybridization was performed as previously shown.14 Once
cut, sections were air-dried onto superfrost slides in the cryostat
for 0.5 hours and then stored in the 280˚C freezer. In situ
hybridization was performed using the RNAScope 2.5 RED
chromogenic assay kit and by following the manufacturer’s
instructions (Advanced Cell Diagnostics, Newark, CA). Briefly,
slides containing tissue sections were removed from the 280˚C
freezer, allowed to equilibrate to RT and rehydrated in phosphate-
buffered saline (PBS). Pretreatment required a hydrogen peroxide
step at RT, followed by an antigen retrieval step and protease
treatment in a hybridization oven at 40˚C. Slides were then
incubated with the target or control probes at 40˚C for 2 hours.
For HAGLR mRNA, the probes were designed to target position
Figure 1.Overview of the computational pipeline used for the identification of novel LncRNAs using RNA-seq data. See Materials and Methods—Identification of
novel LncRNAs and Supplementary Methods, available at http://links.lww.com/PAIN/A676, identification of novel LncRNAs. DE, differentially expressed;
LncRNAs, long noncoding RNAs; UTR, untranslated region.
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1153 to 2443 of NR_110445.1. After probe incubation, slides were
subjected to 6 rounds of amplification, and the probe signal was
developed via a reaction with fast red. To combine with
immunohistochemistry (IHC), tissue sections were then washed
with PBS-Tx (0.3%) and treated with either the isolectin B4 (IB4)
conjugated to biotin (Sigma, Gillingham, United Kingdom, 1:100) or
primary antibodies against NF200 (mouse anti-NF200, Sigma, 1:
250) andCGRP (rabbit anti-CGRP; Peninsula Labs, SanCarlos, CA,
1:1000) overnight at room temperature. IB4 and primary antibodies
were diluted in PBS-Tx (0.3%). Slides were then washed with PBS-
Tx (0.3%) and then incubated with the appropriate secondary
antibody (anti-mouse Pacific Blue or ant-rabbit Alexa 488; Thermo
Fisher Scientific, Abingdon, United Kingdom) or a Pacific blue-
streptavidin (Thermo Fisher Scientific) at a concentration of 1:500 for
3 to 4 hours at room temperature. Slides were then washed,
mounted using Vectashield, and imaged using a confocal micro-
scope (Zeiss, Cambridge, United Kingdom).
3. Results
3.1. Novel long noncoding RNAs expressed in the rodent
dorsal root ganglion
To identify unknown transcribed regions outside known gene
models (ie, representation of RNA transcripts produced by a gene)
and then group them into transcriptional units representing putative
novel LncRNAs on the gene level, we performed RNA-sequencing
(RNA-Seq) of DRG tissue harvested from animal models of nerve
injury vs sham controls. We profiled novel LncRNAs alongside
known annotated protein-coding genes and LncRNAs from the
ENSEMBL genome database.79 To obtain computational predic-
tions of novel LncRNAs, we used a reference-based customised
pipeline45 that relies on a reference genome and gene set
annotations. It uses the output of the STAR18 aligner, and the
quality of predictions is dependent on the aligner accuracy, the
quality of the reference genome, and the completeness of the gene
set annotation. A coverage threshold is used7 to identify non-
annotated continuously transcribed regions,22 ie, I.o.E., and then
clustered together and trimmed these regions using de novo
identified SJs from mapping the RNA-seq reads to the organism’s
genome. We also applied a signal processing, smoothed z-score
thresholding algorithm to further identify coverage drops (putative
introns and transcription ends) and peaks (putative exons). To
identify nonannotated I.o.E and to differentiate them from UTRs or
not-yet-annotated exons belonging to known gene models, we
filtered out reads overlapping ENSEMBL andRefSeq annotations as
well as genomic regions of 1000 bp from the 59 and 39 end of known
gene models. Doing so, we have excluded any predictions
overlapping with a region of 1000 bp from both ends of annotated
gene models. The mean length of 39 UTRs is 424 bp and 524 bp in
rodents and humans, respectively. For the 59 UTRs, mean lengths
are 127 bp in rodents and 146 bp in humans.55We should note that
we used both major annotation consortia, so an incomplete gene
annotation (ie, missing exons, UTRs, and isoforms) in just one of the
annotated gene sets would not influence results. Given the fact that
we discarded all predictions overlapping annotated genes, we could
not also identify extracoding RNAs, as these overlap protein-coding
genes on the sense strand.62
32.6% of read pairs on average were overlapping regions
outside gene models (as we used paired-end data, the units of
evidence for gene expression are always pairs of reads). This
finding is consistent with Ref. 22.
To acquire a complete representation of the nonannotated
transcribed regions, we intentionally applied a low coverage
threshold (.2 sequence coverage for the region) for at least the
length of an RNA-seq read ($100 bp). The cutoff threshold is
similar to the one applied in Ref. 22. Then, we clustered and
trimmed these regions using splicing information from novel SJs
identified by at least 2 RNA-seq read-pairs and a smoothed z-
score over a rolling window to identify coverage drops. To predict
and analyse LncRNAs on the gene level, we merged together all
identified transcripts from individual samples to create a unified
set of nonredundant, novel, putative LncRNAs in the form of
a GTF file. The bioinformatic workflow is illustrated in Figure 1; for
more details, see methods.
We then calculated the coding potential and performed
transcriptional profiling to identify DE novel and known gene
models between animal models of peripheral neuropathy and
control (sham surgery) samples. To perform DE analysis without
overestimating fold changes for lowly expressed transcripts, we
used the analysis software DESeq242 and filtered DE results
according to expression levels and consistency. Significant cutoff
for DE was adjusted P value ,0.05 in all cases. We filtered out
novel LncRNAs that were not expressed in at least all replicates of
a condition or strain or were below an average expression
threshold of .0.5 fpkm in at least one condition. We particularly
focused on antisense LncRNAs, ie, overlapping exonic regions of
the gene on the opposite strand, and intergenic LncRNAs, lying
on the intergenic space between known gene models. All
expression data including antisense and intergenic LncRNAs
are available in http://www.painnetworks.org,54 and all RNA-seq
data (raw data and the whole gene set, ie, novel LncRNAs and
annotated genes) are available in Gene Expression Omnibus
(GEO) (GSE107182, GSE107180, and GSE107181). Supple-
mental spreadsheets of the complete data set are available at
http://doi.org/10.6084/m9.figshare.6508205.
LncRNAs are known to have relatively poor conservation
between species, so we aimed to compare one rat (Wistar) and 2
mouse strains (BALB/c and B10.D2 strains). RNA-seq quality
was good for both experiments (supplementary tables 1–4,
available at http://links.lww.com/PAIN/A676). Quality was
assessed based on: the percentage of uniquely mapped reads
(89% for mice and 72.51% for rats), the number of properly and
concordantly paired reads, the average Phred score for read
quality (32.2 for mice and 34.3 for rats), the base calling at the
extremities of reads (0.08 for mice and 0 for rats, low Phred
scores at the end of reads), the median of the insert between
paired readmates (192.1 for mice and 153.4 for rats), and the GC
content of reads for all sequencing lanes and samples (48.2% for
mice and 51.4% for rats). Two mouse samples were excluded
because they had much lower mapped reads (sample 59:
73.3%), a very high percentage of unmapped reads because they
were too short (sample 59: 18.1%), much more reads mapped to
multiple loci (sample 66 and sample 59), and higher Cook’s
distance (supplementary figure 1, available at http://link-
s.lww.com/PAIN/A676). Uniquely mapped read pairs were used
for the downstream analysis. Raw and processed gene
expression data are available in GEO.
In total, we had on average 64 million uniquely aligned pairs of
reads per sample for mice and 41 million pairs of reads for rats,
more than enough both for identification of de novo LncRNAs and
then to ask whether they were DE in injury vs sham conditions.19
Using this approach, we initially identified and reconstructed
thousands of nonannotated transcribed loci in the mouse and rat
DRG with length of more than 200 bp. Then, we evaluated
whether these novel transcripts were protein coding or non-
coding. After coding potential calculation using the coding
potential calculator CPAT,72 we obtained 6657 long consistently
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expressed transcripts classified as noncoding in the rat DRG and
4729 in the mouse DRG. Four thousand three hundred fifteen of
these passed the expression threshold in rats and 2693 in mice
and were retained for the downstream analysis. These long novel
transcripts with no coding potential were considered putative
novel LncRNAs. Themajority of novel LncRNAswere intergenic in
both species, with 21% and 13% antisense (overlapping exonic
regions of protein-coding genes on the opposite strand) in the
mouse and rat DRG, respectively (Figs. 2A and B). Most novel
LncRNAs were multiexonic, with a distribution of exons heavily
skewed towards biexonic transcripts (Figs. 2C and D). This exon
distribution is very similar to GENCODE findings.27
The usage of ribodepleted RNA for the library preparation
allowed us to completely sample and interrogate the noncoding
transcriptome and led to a relatively high proportion of intronic
noncoding transcripts being identified.29
To increase confidence and to gather more evidence regarding
the completeness and expression of predicted novel LncRNAs,
we examined the relationship between their genomic loci and
annotated TSS. To do this, we used 59 CAGE (cap analysis gene
expression) TSS data40 that are available in the mouse. CAGE is
a technique for high-throughput identification of sequence tags
corresponding to 59 ends of RNA at the cap sites and the
identification of the TSS.65 As TSS data were not available for the
mouse reference genome mm10, we translated and mapped
coordinates from themm9 genome tomm10.We then calculated
the kernel density of the distance between the TSS that were
mapped to mouse genome mm10 (51% of the TSS available for
Figure 2. Attributes of novel LncRNAs identified in mice and rats. (A and B) Classification of novel LncRNAs according to genomic context in mice (A) and rats (B).
(C and D) Exon distribution of novel LncRNAs in mice (C) and rats (D). (E) Kernel density of distances between novel LncRNAs and 59 CAGE TSS. Distance is
measured in genomic bases. Outlying distances.1.53 IQR of the distribution were removed (all data in supplementary figure 2 available, at http://links.lww.com/
PAIN/A676). Median distance of TSS is 0 bp of the predicted LncRNA transcript. DRG, dorsal root ganglion; IQR, interquartile range; LncRNAs, long noncoding
RNAs; TSS, transcription start sites.
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mm9) and a region within 100 bp of the 59 end of the putative
LncRNA similarly to Ref. 27. For both known and novel LncRNAs,
the kernel density was highest at 0 but with more spread for the
novel LncRNAs (Fig. 2E, supplementary Figure 2; available at
http://links.lww.com/PAIN/A676). 33.7% of the antisense and
intergenic LncRNAs had a predicted TSS on their 59 end on the
same strand of the genome. When we removed the outlying
distant TSS—ie, more than 1.5 times the interquantile range of
the distribution—the mean distance of TSS and novel LncRNAs
was 119 bp upstream of the predicted transcript. In a GENCODE
study,27 15%of identified LncRNAs in humans had a TSS on their
59 end. These results highlight how close the 59 end of novel
LncRNAs was to experimentally determined TSS. Due to the fact
that only a fraction of TSS were mapped to the current mouse
genome, these data are likely to be an underestimate. These
findings are in concordance with those of Ref. 17. We also note
that a significant fraction of novel LncRNAs are either incomplete,
not yet annotated extended UTRs or that LncRNAs are indeed
Figure 3. Features of LncRNA’s expression. (A) Median read counts of LncRNAs (novel and ENSEMBL annotated) vs protein-coding genes in mice and rats. Data
are presented as mean plus SEM. Significance was assessed with the Mann–Whitney U test (MWW). (B) Principal component analysis plot of the expression of
novel LncRNAs in different DRGneuron subtypes. Neuron subtypes are as follows: 1.MHN, 2.MHN (MI, IS), 3. C-LTMR, 4.MHN (IS), 5.MHN (IS), 6.MHN, 7.MHN
(NS), 8. MR, 9. MHN, and 10. MR. Axis represents PCs and shows percentage of original data’s variance explained by the respective PC (PCA plot of ENSEMBL
genes in supplementary figure 3A, available at http://links.lww.com/PAIN/A676). (C) Neuron subtype specificity (tau . 0.8, average log 2 counts. 3 for at least
one neuron subtype). Enrichment was assessed with the Fisher exact test for count data. Kernel density of the Tau specificity metric in supplementary figure 3B
(available at http://links.lww.com/PAIN/A676). (D) Distribution of neuron subtype–specific novel LncRNAs in different neuron subtypes. C-LTMR, c-fiber low-
threshold mechanoreceptors; DRG, dorsal root ganglion; IS, itch sensitive; LncRNAs, long noncoding RNAs; MHN, mechanoheat receptors; MI, mechanically
insensitive; MN, mechanical nociceptor; MR, mechanoreceptor; MS, mechanically sensitive; PCA, principal component analysis. P, 0.05*, P, 0.01**, and P,
0.001***.
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independent transcription units arising from TSS that are not yet
annotated, possibly due to their low expression level.
In both species, we found that LncRNAs were significantly and
consistently expressed at a lower level than protein-coding genes
(Fig. 3A). This ratio of about 10-fold lower expression of LncRNAs
to protein-coding genes is similar to previous studies.69,76
Nociceptors are amajor component of the DRG, and a number
of pain genes are selectively expressed by these neurons. We
therefore studied the genomic context of identified LncRNAs, and
in particular, whether they were antisense or in close genomic
proximity with known pain genes downloaded from the Pain
Genes Database.35 The Pain Genes Database catalogues genes
that have been shown to have an impact on pain-related
behaviour in rodents based on transgenic knockout experiments.
Of the 449 genes in the database, we have found 13 novel
LncRNAs antisense to pain genes in mice and 19 in rats
(supplementary tables 5 and 6, available at http://links.lww.com/
PAIN/A676). Twenty-three intergenic LncRNAs had a pain gene
as their closest genomic neighbour in mice and 57 in rats
(supplementary tables 7 and 8 available at http://links.lww.com/
PAIN/A676). Ion channels are key determinants of sensory
neuron excitability. We identified LncRNAs antisense to voltage-
gated sodium channels, potassium channels, calcium channels,
chloride channels, and TRP channels, within the mouse and rat
DRG, as shown in supplementary tables 9 and 10 (available at
http://links.lww.com/PAIN/A676).
In general, we had modest syntenic conservation (ie, in
equivalent genomic positions) between species. We used
synteny portal37 to retrieve synteny blocks conserved between
the human (GRCh38.88), mouse (mm10), and rat (rn5) with
a resolution of 150,000 bp. We lifted genomic coordinates from
rn5 to rn6 genome and found in total 912 conserved synteny
blocks in humans and mice and 443 uniquely mapped in the
current rat genome. Eight hundred (18.5%) novel LncRNAs in rats
and 1271 (47%) in mice were in these syntenic blocks conserved
between the 3 species. Moreover, 649 LncRNAs in mice and 782
in rats were in 200 common syntenic blocks between the 2
species (supplementary data available at http://doi.org/10.6084/
m9.figshare.6508205, S. Data 1). Five hundred nine LncRNAs in
rats and 397 in mice were antisense of the same orthologous
genes in mice and rats (S. Data 2 and 3, available at http://
doi.org/10.6084/m9.figshare.6508205).
3.2. Different types of dorsal root ganglion neurons
selectively express LncRNAs
Dorsal root ganglion neurons are heterogenous both in terms of
physiology and molecular profile; to identify whether the
expression of LncRNA may be DRG subtype–specific, we
reanalysed a published data set of single-cell RNA sequencing
data38 derived from C57BL/6 mouse DRG neurons for expres-
sion of the novel LncRNAs that we had identified. The authors had
previously generated 10 different DRG neuron subtypes from
their analysis of 197 neurons. We found that we could effectively
identify transcriptome- and size-based neuronal types based on
the selective expression of both ENSEMBL annotated genes and
our novel LncRNAs.
Principal component analyses of the expression set of novel
LncRNAs showed that samples belonging to most of the sensory
neuron subtypes were clustered together (Fig. 3B) but with
a higher spread than for annotated genes (supplementary figure
3A, available at http://links.lww.com/PAIN/A676), suggesting
that these can be important transcriptional units the expression of
which is highly related to the different subtypes of DRG neurons.
We then used the Tau tissue specificity metric77 to identify
highly DRG subtype–specific LncRNAs expressed in the mouse
DRG. The density plot of the Tau index distribution (supplemen-
tary figure 3B, available at http://links.lww.com/PAIN/A676; and
S. Data 4, available at http://doi.org/10.6084/m9.fig-
share.6508205) suggested that the Tau.0.8 was an appropriate
threshold for separating neuron subtype–specific from ubiquitous
annotated genes and novel LncRNAs. To consider a gene or
LncRNA neuron subtype–specific, we also imposed a cutoff
mean expression threshold of .3 log2-normalised read pairs
across all samples of a neuronal subtype. Eighty-seven novel
LncRNAs, 119 annotated LncRNAs, and 597 protein-coding
genes were neuron subtype–specific. This reveals a significant
(Fisher exact test P value ,0.001) enrichment of novel and
annotated LncRNAs among the neuron subtype–specific tran-
scripts (Fig. 3C). This quantification of the DRG subtype
specificity confirms that LncRNAs’ expression pattern is more
tissue specific than protein-coding genes’. In studying the
different DRG subtypes (as defined by Li et al., 2016), we noted
that there was an uneven distribution of subtype-specific
LncRNAs, Figure 3D.
3.3. IPSC-derived sensory neurons differentially express
known and novel LncRNAs compared with their respective
IPS cells
We assessed LncRNA expression in human IPSC–derived
sensory neurons generated from healthy individuals. We followed
a differentiation protocol known to produce neurons with a gene
expression profile and functional characteristics that are very
similar to rodent sensory neurons.8,11,80 Virtually, all the resulting
neurons express the sensory neuron marker Brn3a, project
extensively arborized neurites, a subset can be myelinated and
exhibit mature electrophysiological characteristics of sensory
afferents.8,73 At least 84% of the ion channel genes known to be
expressed in the human DRG were shown to be expressed by
sensory neurons generated using this protocol.80 We compared
gene expression in IPSC-derived sensory neurons with expres-
sion in IPSC parent lines to focus on LncRNAs enriched in
differentiated sensory neurons (GEO GSE107181, S. data 5–7,
available at http://doi.org/10.6084/m9.figshare.6508205). We
first interrogated genes annotated in the ENSEMBL GRCh38.88
gene set, andwe also identified and profiled 2948 novel LncRNAs
in human IPSC and IPSC-derived sensory neurons, most of them
were intergenic (Fig. 4A) and biexonic (Fig. 4B). Again, we found
that LncRNAs were significantly lower expressed than protein-
coding RNAs (Fig. 4C). IPSC-derived sensory neurons from 3
different cell lines (identified as AD2, AD4, and NHDF) were very
similar to each other and considerably different to the IPSCparent
lines (supplementary figure 4A, available at http://links.lww.com/
PAIN/A676). Forty-two percent of all expressed genes were DE in
IPSC-derived sensory neurons vs IPSCs, which is a remarkable
transcriptional change. A total of 6103 annotated LncRNAs
(ENSEMBL GRCh38.88) were consistently expressed in at least
all samples of either IPSCs or IPSC-derived sensory neurons. A
total of 1830 (30%) of them were significantly DE in all 3 cell lines
between IPSC-derived sensory neurons and IPSCs; the majority
of these were intergenic (47%). Seventy-seven percent of the
expressed novel LncRNAs were significantly DE between IPSC-
derived sensory neurons and IPS cells. All 3 cell lines had in
common 371 novel LncRNAs significantly DE.
In both annotated and novel intergenic LncRNAs, distance was
modestly but significantly anticorrelatedwith expression correlation
with their closest genomic neighbour (supplementary figure 4B, C;
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Figure 4. Expression patterns of LncRNAs in human IPSC–derived neurons. (A) Classification of novel LncRNAs according to genomic context. (B) Exon
distribution of novel LncRNAs. (C) Median read counts of LncRNAs (novel and ENSEMBL annotated) vs protein-coding genes in human IPSC–derived neurons.
Data are presented as mean plus SEM. Significance was assessed with the Mann–Whitney U test (MWW). (D) Heatmap of novel and annotated intergenic
LncRNAs DE between human IPSC-derived neurons and IPSC. (E and F) Expression plot of novel antisense LncRNAs (E) and annotated ENSEMBL antisense
LncRNAs (F) vs the sense protein-coding gene. LncRNAs antisense to DE genesKcnj6 and Trpm3were DEwith opposite log2 fold changes to the DE sense gene.
P , 0.05*, P , 0.01**, and P , 0.001***. DE, differentially expressed; LncRNAs, long noncoding RNAs.
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available at http://links.lww.com/PAIN/A676). Two thousand
seven hundred forty-three intergenic LncRNAs (novel and
annotated) were significantly DE between IPSC-derived neu-
rons and IPSC (Fig. 4D). Eighty annotated and 16 novel
LncRNAs were antisense to pain genes (S. Data 8, available at
http://doi.org/10.6084/m9.figshare.6508205), and 15 anno-
tated and 18 novel LncRNAs had a pain gene as its closest
genomic neighbour (S. Data 9, available at http://doi.org/
10.6084/m9.figshare.6508205). Eight of the LncRNAs anti-
sense to pain genes were significantly DE between IPSC-
derived sensory neurons and IPSCs with a significantly DE gene
on the opposite strand and anticorrelated expression changes,
1 of them was novel (supplementary table 11, available at http://
links.lww.com/PAIN/A676). IPSC-derived sensory neurons
expressed LncRNAs (including both annotated and novel
LncRNAs) antisense to TRP, voltage-gated sodium, potassium,
chloride, and calcium ion channels; in some cases, these
showed the opposite expression changes relative to the sense
gene on the opposite strand (Figs. 4E and F).
One example of the antisense LncRNAs, the HOXD Cluster
Antisense RNA 1 (HAGLR) was further investigated because it
was very highly upregulated in neurons vs IPSC, and HoxD genes
have been implicated in nociceptor specification.25 HAGLR was
ranked first among the significantly DE annotated antisense
LncRNAs by its log2 fold change (8.74) and base mean counts
(261.5). Differential expression was validated by qPCR (Fig. 5,
supplementary table 12, available at http://links.lww.com/PAIN/
A676). In situ hybridization also revealed that it was expressed by
mouse DRG cells in vivo, and it was found to be significantly
downregulated in the mouse DRG after nerve injury (see below as
well as Fig. 5).
We also observed similar extent of syntenic conservation
between the human, mouse, and rat in novel LncRNAs identified
in human IPSC and IPSC-derived sensory neurons. One
Figure 5. (A) In situ hybridisation for HAGLR LncRNA (mouse ortholog of human HAGLR) shows expression in the mouse WT L4 DRG. The ISH signal was
developed using a fast red reaction. From right to left: Representative images of mouse DRG sections stained for HAGLR (red), NF200 (blue), CGRP (green), and
IB4 (blue). Scale bar 50mm. (B) Quantification of expression change of HAGLR in human IPSC vs IPSC-derived neurons. Relative expression assessed by qPCR of
HAGLR LncRNA. (C) RNA-seq determined relative expression in SNI vs ShamBALB/c and B10.D2mice DRG. Data are presented as mean plus SEM. P, 0.05*,
P , 0.01**, and P , 0.001***. DRG, dorsal root ganglion; ISH, in situ hybridization; LncRNAs, long noncoding RNAs; qPCR, quantitative real-time polymerase
chain reaction; SNI, spared nerve injury.
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thousand three hundred twelve (44.5%) were in syntenically
conserved blocks between the 3 species. Four hundred fifty-nine
LncRNAs in human IPSC and 495 in mice were in 126 common
syntenic blocks between the 2 species (S. Data 10, available at
http://doi.org/10.6084/m9.figshare.6508205), and 522 were
antisense orthologous genes in humans and mice (S. Data 11,
available at http://doi.org/10.6084/m9.figshare.6508205).
Human DRG eQTLs (expression quantitative trait loci) have
recently been identified and associated with pain phenotypes.52
We interrogated this data set for overlaps with novel and
annotated LncRNAs expressed in IPSC-derived sensory neu-
rons, as this may provide an underlying mechanism through
which a single nucleotide polymorphism (SNP) at this site may
impact on gene expression. We only considered overlaps valid if
they were found on exons of the respective transcript. We found
that 4 annotated LncRNAs (3 antisense and 1 intergenic) that had
DRG eQTLS were expressed in IPSC-derived sensory neurons,
and also that 5 novel LncRNAs were overlapping DRG eQTLS
(Table 1).
3.4. Expression profiling of LncRNAs after nerve injury
We then assessed differential expression of LncRNAs within the
DRG after nerve injury both in rats and mice. We used the SNI
model in mice and the SNT model in rats. We used 2 different
mouse strains: BALB/c and B10.D2, which have previously been
shown to develop different levels of mechanical hypersensitivity
after nerve injury.67
3.4.1. Transcriptional changes of LncRNAs in the rat dorsal
root ganglion
We confirmed that the expression patterns of the top 5000
ENSEMBL annotated genes and novel LncRNAs ranked by their
SD could separate samples according to condition (Fig. 6A). We
also observed a significant transcriptional response after nerve
injury in the rat DRG, which amounts to 25.5% (4215 ENSEMBL
annotated genes 1 novel LncRNAs) of all expressed genes (Fig.
6B, S. Data 12, available at http://doi.org/10.6084/m9.fig-
share.6508205). There was a significant enrichment of BP GO
terms related to ion-channel transport, signal transduction, and
response to mechanical stimulus in the ENSEMBL annotated DE
genes (supplementary figure 5, available at http://links.lww.com/
PAIN/A676). Novel LncRNAs were a substantial component of
the DE genes after peripheral nerve injury (highlighted in Fig. 6B).
Five hundred forty-one of the 3169 annotated LncRNAs in rats
(ENSEMBL Rnor_6.0.92) were expressed in the DRG. Out of
these, 82 (16%) were significantly DE. From the 4316 putative
novel LncRNAs, 708 (16.4%) were significantly DE in rats
(PainNetworks, GEO GSE107180). Of the 629 novel antisense
LncRNAs, 253 (40%) had an anticorrelated expression pattern to
the sense gene after SNT (S. Data 13, available at http://doi.org/
10.6084/m9.figshare.6508205). In total, 31 reach significance
with a significant DE gene on the opposite strand. Nine of them
were significantly DE on the opposite strand of a significantly DE
pain gene with opposite log fold changes (supplementary table
13, available at http://links.lww.com/PAIN/A676). There were
novel LncRNAs antisense of pain genes, voltage-gated potas-
sium and sodium channels (Fig. 6C).
Six hundred fifty-four intergenic LncRNAs were found to be
significantly DE in SNT vs sham, 575 of themwere novel (Fig. 6D,
S. Data 14, available at http://doi.org/10.6084/m9.fig-
share.6508205). Five of them (4 novel and 1 annotated) were
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table 14, available at http://links.lww.com/PAIN/A676). Most
intergenic LncRNAs were positively correlated with their closest
genomic neighbour. Also, the closer they were to their closest
neighbour, the stronger the correlation (supplementary figure 6,
available at http://links.lww.com/PAIN/A676), both for annotated
and novel LncRNAs.
3.4.2. Transcriptional changes of LncRNAs in the mouse
dorsal root ganglion
Withdrawal thresholds to von Frey filament stimulation confirmed
previous findings that the B10.D2 demonstrates less mechanical
pain–related hypersensitivity after SNI than BALB/c67 (Fig. 7A).
There were no significant behavioural differences between male
and female mice for either strain. Principal components analysis
of the expression of the top 10,000 ENSEMBL annotated genes
and novel LncRNAs (ranked by SD) showed that they were able to
optimally separate mouse samples according to sex, strain, and
within them, condition (Fig. 7B).
Volcano plots show the range of transcriptional changes of
ENSEMBL annotated genes and novel LncRNAs in mice after
peripheral nerve injury (Figs. 7C and D, S. Data 15, available at
http://doi.org/10.6084/m9.figshare.6508205). Novel LncRNAs
were a substantial component of the DE genes following the SNI
pain model (highlighted in Figs. 7C and D).
Regarding the BALB/c mouse strain, which showed signifi-
cantly more pain-related hypersensitivity from day 7 onwards
than the B10.D2 strain, we found significantly more DE
ENSEMBL annotated genes and novel LncRNAs, 2750 com-
pared with 1441. In comparison to rats, we found less DE genes
in the mouse after nerve injury. Spinal nerve transection is a more
severe injury model than SNI (in which less sensory neurons are
axotomised and the injury is more distal), and so, this may reflect
model severity rather than species differences.
Figure 6. Dorsal root ganglion transcriptional response in rats after peripheral neuropathy. (A) Principal component analysis plot of samples based on the
regularised log2-transformed counts of novel LncRNAs and ENSEMBL genes (first 5000 genes ranked by their SD) in the rat DRG. Axis represents PCs and shows
percentage of original data’s variance explained by the respective PC. (B) Volcano plot of the whole gene set (ENSEMBL annotated genes and novel LncRNAs). X-
axis Log2(Fold Change), y-axis2log10(FDR adjusted P value). Significantly DE ENSEMBL annotated genes and novel LncRNAs are highlighted. (C) Expression
plot of novel antisense LncRNAs vs the sense protein-coding gene. (D) Heatmap of novel and annotated intergenic LncRNAs DE between SNT and Sham-
operated animals. DE, differentially expressed; DRG, dorsal root ganglion; FDR, false discovery rate; LncRNAs, long noncoding RNAs; PCA, principal component
analysis; SNT, spinal nerve transection.
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In those ENSEMBL annotated genes that were DE, we found
significant GO enrichment in terms related to the nervous system,
regulation of excitability, signal transduction, and response to
injury (supplementary figure 7, available at http://links.lww.com/
PAIN/A676). As novel LncRNAs were not assigned with GO
terms, we used their expression profiling context, in an unbiased
way, to gather more insights regarding their possible functional
importance. Under the assumption that they may regulate gene
expression either in-cis or in-trans, we further studied them in the
context of modules of closely coexpressed genes and associated
them with enriched GO BP terms. We first created a weighted
gene coexpression network (WGCNA)36 and then identified
modules of highly coexpressed ENSEMBL annotated genes
and novel LncRNAs (scale independence and dendrogram of
merged/unmerged modules in supplementary figure 8, available
at http://links.lww.com/PAIN/A676). The absolute weighted
bicorrelation across all samples (n 5 20) was used to construct
the network. An n. 15 is needed to robustly calculate expression
correlations. We also calculated the representative gene (ie,
eigengene) for each module, defined as the first principal
component of the expression of all member genes. We then
quantified the novel LncRNAs’ module membership by calculat-
ing the robust weighted bicorrelation of the LncRNAs with these
eigengenes. Next, we performed a GO enrichment analysis and
annotated each module with its top enriched BP term, based on
an overrepresentation analysis of the annotated genes. The
strength of module membership for novel LncRNAs (Fig. 8A)
shows highly correlated modules of LncRNAs associated with
Figure 7. Dorsal root ganglion transcriptional response in mice after peripheral neuropathy. (A) Hind paw withdrawal thresholds to von Frey filament stimulation1
SEM in grams. We calculated the area over the curve (AOC) for each strain and obtained the percentage of maximum induced hypersensitivity. Two-way ANOVA
showed a significant effect of surgery and a significant interaction of strain:surgery (P5 0.001). One-way ANOVA between SNI groups on D28 showed significant
difference in%ofmaximumhypersensitivity (P5 0.002). Black bar shows comparison between SNI groups,P, 0.01**. N5 12 per strain, N5 6 per SNI group. (B)
Principal component analysis plot of samples based on the expression of novel LncRNAs and ENSEMBL genes (first 10,000 genes ranked by their SD) in the
mouse DRG. Axis represents PCs and show percentage of original data’s variance explained by the respective PC. (C and D) Volcano plots of the whole gene set
for BALB/c strain (C) and B10.D2 strain (D). X-axis Log2(Fold Change), y-axis 2log10(FDR adjusted P value). Significantly DE ENSEMBL annotated genes and
novel LncRNAs are highlighted. ANOVA, analysis of variance; DE, differentially expressed; DRG, dorsal root ganglion; FDR, false discovery rate; LncRNAs, long
noncoding RNAs; SNI, spared nerve injury.
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Figure 8.Network analysis of annotated genes and novel LncRNAs. (A) Heatmap of module membership for novel LncRNAs. Module membership quantified with
absolute bicorrelation. Colours represent z-values of absolute bicorrelation. (B) Distribution of novel LncRNAs in modules enriched with GO terms of Biological
Process (BP). GO, Gene Ontology; LncRNAs, long noncoding RNAs.
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Figure 9.Expressionpatternsof LncRNAs in themouseDRG. (AandB)Expressionplot of annotatedENSEMBLantisenseLncRNAs in theBALB/cmouse (A) andB10.D2
mouse (B). (C and D) Novel antisense LncRNAs vs the sense protein-coding gene in BALB/c (C) and B10.D2 (D) strains. Novel LncRNAs antisense to DE genes Inpp1,
Epyc, Kcnmb1, Nefl, Nalcn, Nbea, Ttc39aos1, Cgref1, and Zyg11b are significantly DE. (E) Heatmap of novel and annotated intergenic LncRNAs DE between SNT and
Sham-operatedanimals. (F)Hierarchical samples’ clusteringbasedon theexpressionofENSEMBLannotatedandnovel LncRNAs inmice.Countswere transformedusing
the regularized log2 transformation; Euclidean distance was used as a dissimilarity measure and complete linkage was used for clustering. Male samples are in blue and
female in pink colour. DE, differentially expressed; DRG, dorsal root ganglion; LncRNAs, long noncoding RNAs; SNI, spared nerve injury; SNT, spinal nerve transection.
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RNA-processing and some related to the nervous system,
signalling, and regeneration. The vast majority of novel LncRNAs
were in the module associated with RNA-processing (Fig. 8B).
Of the 7990 annotated ENSEMBL (GRCm38.87) LncRNAs,
2406 were expressed in themouse DRG. A total of 296 LncRNAs
were significantly DE in BALB/c strain SNI vs sham, 193 of them
were novel. In B10.D2 strain, 146 LncRNAs, 97 of which were
novel, were significantly DE (PainNetworks and GEO
GSE107180). Although the absolute numbers are much smaller
in comparison with annotated genes, percentages of significantly
dysregulated transcripts are similar. Most of themwere intergenic
(S. Data 16, available at http://doi.org/10.6084/m9.fig-
share.6508205) and antisense (S. Data 17, available at http://
doi.org/10.6084/m9.figshare.6508205).
Forty percent of the 1776 annotated antisense LncRNAs in
mice had an anticorrelated expression pattern with their sense
gene (Figs. 9A and B). 44.8% of the novel antisense LncRNAs
had opposite fold changes in comparison with their protein-
coding gene on the opposite strand (Figs. 9C and D). Some
demonstrated the opposite expression pattern to their sense
gene after nerve injury (Figs. 9A–D, supplementary table 15,
available at http://links.lww.com/PAIN/A676). The significantly
DE LncRNAs antisense to sodium and potassium channels are in
supplementary table 16 (available at http://links.lww.com/PAIN/
A676). Themajority of LncRNAs antisense to potassium channels
were downregulated after nerve injury and between IPSC-derived
neurons and IPSC. On the other hand, although the LncRNA
antisense to Scn9awas downregulated after nerve injury, all other
LncRNAs antisense to sodium channels were upregulated in
IPSC-derived neurons vs IPSC. In some cases, these showed an
opposite expression pattern to their sense gene.
In total, 2365 intergenic LncRNAs were expressed in the
mouse DRG, 1282 of themwere novel, and 126were significantly
DE in mouse SNI vs Sham (Fig. 9E). Similarly to rats and humans,
intergenic LncRNAs showed positive correlation with their
adjacent gene (supplementary figure 9, available at http://
links.lww.com/PAIN/A676). Twenty-three novel and 18 known
intergenic LncRNAs were adjacent to pain genes in mice. Two of
these novel intergenic LncRNAs were significantly DE and highly
correlated with their adjacent pain gene (supplementary table 17,
available at http://links.lww.com/PAIN/A676). In some cases,
multiple novel LncRNAs related to coding genes in the same pain-
related signalling pathway could be identified andwere DE inmice
and rats. For instance, 2 intergenic LncRNAs upstream of the
opioid receptor genes, Oprl1 and Oprd1, were significantly DE
and highly correlated with their adjacent significantly DE gene in
both species. Oprl1 and Oprd1 form heterodimers and appear in
the same network of highly correlated genes.54
We also performed unsupervised clustering of samples based
on the expression of all novel and annotated LncRNAs. We
observed a pattern of highly sex-specific expression changes
within strains and then, within sex, we had separation according
to condition (Fig. 9F). This indicated that LncRNAs are
dysregulated after peripheral nerve injury in a sex- and strain-
dependent manner.
We selected and validated 7 representative novel LncRNAs
based on the expression strength, the significance and size of the
effect (log2 fold change), and the genomic context. These novel
LncRNAswereall found tobesignificantlyDE in themouseDRGafter
nerve injury and among these are antisense and intergenic, table 2
(primers in supplementary table 18, primer binding in supplementary
figure 10, available at http://links.lww.com/PAIN/A676).
Quantitative real-time polymerase chain reaction confirmed the
expression of these novel LncRNAs in the mouse DRG and
validated their dysregulation after nerve injury, Figure 10.With the
exception of 1 LncRNA, these all demonstrated higher expres-
sion in the DRG compared with brain (Fig. 10E). This
comprehensive study47 showed that upstream of genes where
these LncRNAs lie, there were no previously unannotated
lengthened 39 UTRs. With the exception of LncRNA4714,
upstream of Oprd1, where the multiexonic transcript we have
identified is much longer than any predicted elongated UTR.
When studying the changes in LncRNA expression evoked by
SNI in B10.D2 and BALB/c mouse strains, there was in general
good agreement between RNA-seq and qPCR findings. We also
found that in all cases, where RNA-sequencing showed
significant dysregulation, qPCR confirmed the result (Fig. 10).
4. Discussion
We used high-depth RNA sequencing and a dedicated bio-
informatic pipeline to identify thousands of known and putative
novel LncRNAs expressed in the mouse and rat DRG and human
IPSC–derived sensory neurons. Many of these LncRNAs were
Table 2
Representative qPCR validated novel LncRNAs.
Base mean BALB/c mouse B10.D2 mouse Genomic context
Log2, fold change FDR-adjusted, P Log2, fold change FDR-adjusted, P
LncRNA2754 194.6 20.53 0.002 20.49 0.006 Antisense of Nefl (neurofilament protein and light
chain)
LncRNA1528 112.6 20.5 0.007 20.45 0.02 Antisense of Htra1 (high-temperature requirement
a serine peptidase 1)
LncRNA1779 615.0 20.42 0.001 20.44 ,0.001 Intergenic upstream to Scn4b (Sodium voltage-
gated channel beta subunit 4)
LncRNA1291 79.96 20.07 0.96 22.57 0.007 Intergenic downstream to Lrrc4 (leucine-rich repeat
containing 4—related to axon guidance)
LncRNA4834 413.3 0.77 ,0.001 0.29 0.04 Intergenic upstream to Cdc7 (cell division cycle 7)
LncRNA4714 445.4 20.77 ,0.001 20.66 ,0.001 Intergenic upstream to Oprd1 (opioid receptor
delta 1)
LncRNA561 76.8 0.56 0.007 20.05 0.91 Intergenic
Base mean column holds average library size normalised counts across sham samples.
FDR, false discovery rate; LncRNAs, long noncoding RNAs; qPCR, quantitative real-time polymerase chain reaction.
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Figure 10. Relative expression of 7 novel LncRNAs in the SNI vs Shammouse DRG assessed by qPCR and RNA-seq. (A and C) Relative expression assessed by RNA-
seq. RNA-seq counts were normalised by the sham average and the effective library size using DESeq2. Significance as obtained by DESeq2 using the following GLM;
sex1 strain3condition for thewhole gene set of ENSEMBL annotated genes and novel LncRNAs, N5 10 per strain (6 Sham–4SNI BALB/c, 5 Sham–5SNI B10.D2). (B
andD) Relative expression assessedby qPCR. Expressionwas normalized against the average expression in Sham. Significancewas obtained using a 1-wayANOVAand
the linearmodel; sex1 condition, N5 10 per strain. (E) Relative expression of 7 novel LncRNAs in brain vs DRG. Expression wasmeasured by qPCR using the delta CT
method. Expression was normalized against the average expression in the brain. Data are presented as mean plus SEM. P, 0.05*, P, 0.01**, and P, 0.001***, same
direction of change betweenRNA-seq and qPCR#. X indicates strand-specific RT-PCR,N5 8 for B10.D2 (5 Shamand 3SNI). ANOVA, analysis of variance; DRG, dorsal
root ganglion; LncRNAs, long noncoding RNAs; qPCR, quantitative real-time polymerase chain reaction; SNI, spared nerve injury.
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antisense or adjacent to known pain and ion-channel genes. A
significant proportion demonstrated selective expression in DRG
neuron subtypes. Novel LncRNAs were DE after peripheral nerve
injury in a species- and strain-dependent manner, including novel
antisense LncRNAswith opposite transcriptional changes to their
sense genes and intergenic LncRNAs highly correlated with their
adjacent gene. Thus, LncRNAs that have been a relatively
unexplored part of the DRG transcriptome demonstrate remark-
able complexity in terms of their relationship to genes known to
impact on sensory function, DRG cell-type–specific expression,
and the transcriptional response to nerve injury.
LncRNAs have been shown to be: smaller than protein-coding
genes, spliced, biexonic, transcribed as independent transcrip-
tion units, expressed at a lower level than protein-coding genes,
and show highly spatially constrained correlation with their
antisense and adjacent genes.17,69,81 These characteristics are
highly consistent with the antisense and intergenic LncRNAs that
we identified in this study as being expressed in the DRG.
No previous attempts have comprehensively determined
LncRNA expression within the DRG. Previous studies have
undertaken a candidate gene approach,32,86 whereas others have
used a high-throughput approach such as RNA-seq but have only
interrogated the expression of previously annotated
LncRNAs.24,30,75 As we have shown, this strategy will miss
thousands of unannotated and potentially important LncRNAs. In
fact, 8% of genes within the Pain Genes Database in the mouse,
16% in the rats, and 7% in human IPSC were found to have an
antisense or neighbouring intergenic LncRNA. Furthermore,
LncRNAs antisense to ion channels were not limited to KCNA2
and SCN9A, but could also be identified to other sodium,
potassium, calcium, and also TRP channels, all of which have
key roles in modulating sensory neuron function. As with all
computational predictions, this study has the limitation of the
possible inclusion of false positives in our list of novel LncRNAs;
however, we have validated the expression of a number of novel
LncRNAs using the independent technique of qPCR.
It is known that LncRNAs can be highly tissue- and cell-
type–specific.57,68 Dorsal root ganglion cells are heterogeneous
in terms of their physiology, anatomy, and connectivity; recent
single-cell analysis shows how gene expression relates to such
specialised features but also reveals even greater complexity in
DRG subtypes based onmolecular profiling.38,70We showed that
both novel and annotated LncRNAs demonstrate selective
expression within sensory neuron subtypes. As such, identifica-
tion of LncRNAs may help in the molecular classification of DRG
cells. Moreover, both novel and annotated LncRNAs were
significantly enriched in neuron-subtype–specific genes vs
protein-coding genes. The functional specialisation of different
neuron subtypes will principally arise due to the neuron subtype–
dependent expression of protein-coding genes; however, such
expression may be sculpted by LncRNAs.
We have also defined LncRNAs expressed in human IPSC-
derived sensory neurons. Advantages of studying LncRNA expres-
sion in this model (rather than, eg, cadaveric human DRG) is the
ready source of high-quality RNA from a pure sensory neuronal
population (with very few contaminating Schwann cells) and the
ability to compare expression to theparent IPSC line.Disadvantages
include the fact that although subpopulations of sensory neurons
exist in these cultures, these are not as diverse as native DRG cells
and are less mature given the lack of target interactions.
We identified almost 2000 previously annotated and over 2000
novel putative LncRNAs, which were DE when comparing IPSC-
derived sensory neurons and parent IPSC lines. These demon-
strated many characteristics of the LncRNAs expressed in the
rodent DRG. Twenty-nine percent of genes in the Pain Genes
Database had a potentially relevant relationship to a novel or
annotated LncRNA either antisense LncRNAs on the opposite
strand or adjacent to an intergenic LncRNA. Interestingly, some of
these LncRNAs may have a role in shaping the expression of the
sense pain gene during differentiation, as both novel and
annotated, DE antisense LncRNAs demonstrated anticorrelated
expression changes to their DE sense pain gene. We also identified
human LncRNAs that were antisense to voltage-gated ion channel
genes. It has been shown that many LncRNAs overlap genome-
wide association studies’ traits, and LncRNAs overlapping trait-
associated SNPs are specifically expressed in cell types relevant to
the traits.28 The identification of human LncRNAs expressed in
IPSC-derived sensory neurons may therefore enable investigation
of the genetic basis of chronic pain states in humans, especially
under conditions of neuropathic pain whereinmaladaptive plasticity
in the DRG is an important pathophysiological driver. A recent study
has mapped eQTLs in the human DRG,52 and a number of SNPs
that impacted on gene expression were found to be within
annotated LncRNAs. In our data, 9 LncRNAs expressed in IPSC-
derived sensory neurons were overlapped by eQTLs. Three of the
novel and 3 of the knownwere also DE in IPSC-derived neurons vs
IPSC. Dorsal root ganglion eQTLs identified by Ref. 52 were found
among hits in numerous genome-wide association studies. Such
studies highlight the utility in identifying LncRNAs, in this case by
providing explanatory power as to how an SNP linked to complex
disordersmay impact on gene expression and phenotype. Asmore
tissue becomes available for RNA-seq, it will also be possible to
extend LncRNA discovery to the postmortem human DRG.60
Nerve injury is known to elicit remarkable transcriptional
changes within the DRG, which has deleterious consequences
such as neuropathic pain, but in certain contexts can also be
adaptive; eg, by promoting nerve repair.51 We investigated the
expression of LncRNAs in Wistar rats after SNT and in 2 different
mouse strains after SNI. The BALB/c strain was previously shown
to develop greater levels of mechanical hypersensitivity after SNI
vs the B10.D2 strain.67 Hundreds of LncRNAs were DE in both
rats and mice after nerve injury. We found that more protein-
coding genes, annotated LncRNAs, and novel LncRNAswere DE
in the high pain BALB/c strain compared with the low pain
B10.D2 strain. Most of the variance of the LncRNAs’ expression
in our data set was between strains and not conditions; namely,
LncRNAs demonstrated strain-dependent expression plasticity
after nerve injury. Twenty-seven percent of LncRNAs were
significantly DE between mouse strains compared with 12.2%
for ENSEMBL protein-coding genes. Considering the rapidly
increasing literature on sex differences in pain processing48,66
that there were sex-dependent effects on LncRNA expression.
Weightedgenecoexpressionnetwork analysis revealed that novel
LncRNAs in the mouse DRG were in network modules related to
RNA-processing and some of them in modules related to
myelination, development, and regeneration of the nervous system,
immune response, and signalling. This could indicate that these
LncRNAs function together with genes acting as transcriptional
regulators associated with posttranscriptional modifications. This
enrichment is different from that observed in the ENSEMBL
annotated gene set, where terms related to axon guidance, ion
channel transport, regulation of synapse assembly and of neuron
apoptotic process, nervous systemdevelopment, andmemorywere
significantly enriched. These findings are similar to known biological
processes enriched after nerve injury83,84 and in pain genes.41
Enrichment in biological processes of splicing, mRNA process-
ing, and polyadenylation (ie, parent, child, and related terms to
RNA-processing) has however been reported.82,83 Our finding that
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the expression of novel LncRNAs changes togetherwith annotated
genes regulating RNA-processing is consistent with known
mechanisms by which LncRNAs alter gene expression (discussed
below).
LncRNAs can regulate expression in cis and in trans,33 but the
genomic context of LncRNAs is important for both antisense
transcripts regulating the gene on the sense strand or intergenic
LncRNAs. Intergenic and antisense LncRNAs, which tend to lie in
genomic regions populated with genes,31 have correlated expres-
sion patterns with their adjacent genes and may regulate gene
expression (Fig. 4).58 We found that the shorter the distance, the
stronger the correlation in all species, both for known and annotated
LncRNAs. However, the network analysis we performed allowed us
to identify in an unbiased way modules of highly correlated genes
and LncRNAs across all samples. Thus, these LncRNAs are
putative both in-cis and in-trans regulators. Regarding the relation of
LncRNAswith their genomic context, we found thatmore than 45%
of antisense LncRNAs had anticorrelated—opposite expression
changes in respect to the sense gene, whereas only 10% of
intergenic LncRNAs had negative correlation with the expression of
their closest genomic neighbour. Twelve pairs of antisense
LncRNA/sense gene with opposite LFCs reached significance
between pain models and control animals. These antisense
LncRNAs fit into the paradigm ofKcna2 antisense,86 which silences
the gene on the opposite strand. LncRNAs are also known for
regulating clusters of imprinted genes or close genes such as the
Hoxd cluster.43,78 One of these LncRNAs, HAGLR, was the most
upregulated and stronger expressed LncRNA in human IPSC–
derived neurons and was also found by in situ hybridization to be
expressed in the mouse DRG and significantly downregulated in
both mouse strains after nerve injury (supplementary table 12,
available at http://links.lww.com/PAIN/A676).
We used qPCR to validate the expression of a number of novel
LncRNAs in close genomic relationship to protein-coding genes of
relevance to sensory function: A novel LncRNA antisense of Nefl
gene implicated in the Charcot–Marie–Tooth disease,85 and an
intergenic LncRNA close to and highly correlated with the pain
gene Oprd1 was found DE and validated with qPCR. We also
describe a novel intergenic LncRNA in close proximity to the Lrrc4
gene that relates to axon guidance and synapse organisation,16,74
and finally, a significantly DE intergenic LncRNA was validated
close to the voltage-gated sodium channel subunit Scn4b. The
majority of LncRNAs validated by qPCR were found to be more
highly expressed in the DRG than brain. LncRNAs are putative
therapeutic agents that could regulate the expression of target
genes related to disease.71 Although application of such thera-
peutics to pain would need to overcome the hurdle of delivering
therapeutics to DRG cell bodies.
In summary, we have provided a resource, in which we have
defined LncRNA expression within the DRG across species. We
show that marked changes in LncRNA expression occur after
nerve injury and during sensory neuron differentiation. LncRNAs’
expression is DRG subtype–specific, and there is often highly
spatially constrained correlation/anticorrelation with their anti-
sense and adjacent genes.
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